The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain … (NCT07415707) | Clinical Trial Compass
RecruitingNot Applicable
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
United States20 participantsStarted 2026-02-26
Plain-language summary
The goal of this pilot study is to explore a combination of two interventions: (1) a behavioral alcohol-reduction intervention using motivational interviewing, and (2) a blinded probiotic microbiome or placebo intervention. The study examines whether these interventions improve cognitive and neurophysiological function, including brain metabolism, in older adults who are high-risk alcohol drinkers.
Who can participate
Age range
65 Years – 84 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Between 65 and 84 years of age
* English speaking
* Able to provide valid informed consent, understand requirement and risk/benefits of the study and comply with study protocol
* Heavy drinker defined as \>14 alcoholic drinks/week for men and \>7 drinks/week for women
* Interested in reducing their alcohol consumption
Exclusion Criteria:
* BMI ≥ 35
* Fasting Glucose \> 125 mg/dL
* Current or previously diagnosed with Type 1 or 2 Diabetes
* Requires the use of insulin and/or other glucose lowering agents
* Unable to fast for 12 hours
* Past serious alcohol withdrawal symptoms
* MRI Contraindications (e.g., certain devices and implants, claustrophobic)
* Diagnosed with a neurodegenerative disease (e.g., Alzheimer's Disease)
* Diagnosed with a psychotic disorder
* Current substance dependence diagnosis (except for mild or moderate alcohol)
* Consumption of over 300 drinks in the past 30 days
* Current probiotic use or recent probiotic use within the past 30 days
* Current antibiotic use or recent antibiotic use within the past 30 days
* In active cancer treatment and/or have advanced cancer
* Taking daily steroids and/or immunosuppressants
* Lifetime organ or bone marrow transplant; primary immunodeficiency (e.g., DiGeorge syndrome or Wiskott-Aldrich syndrome) or transplant recipient or prescribed immunosuppressant medications
* PI's discretion
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.